Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
ClinicalTrials.gov study NCT06488222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT01938729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
ClinicalTrials.gov study NCT03093922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00491127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
ClinicalTrials.gov study NCT03579836. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
ClinicalTrials.gov study NCT00006105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT03081039. IPD Sharing: NO. Countries: 1. Publications: 0.
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT06298968. IPD Sharing: NO. Countries: 1. Publications: 0.
A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer
ClinicalTrials.gov study NCT00191672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
ClinicalTrials.gov study NCT00293345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
ClinicalTrials.gov study NCT00307255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01797913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen
ClinicalTrials.gov study NCT00191971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
ClinicalTrials.gov study NCT06001658. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00401128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
ClinicalTrials.gov study NCT04051047. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
ClinicalTrials.gov study NCT03278015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00504192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT05660993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00159458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.